This content is in French.
Tofacitinib in vitiligo
2 avril 2024
Vitiligo is a skin depigmentation disease resulting from the destruction of melanocytes, often concomitant with autoimmune diseases such as hyperthyroidism or systemic lupus erythematosus. The efficacy of available…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Qingxia Lin et al. A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib. Clin Cosmet Investig Dermatol. 2024 Mar 20:17:707-711
View the sourceOther recent articles
Advanced hepatocellular carcinoma in Europe: a rapidly evolving treatment landscape
27 octobre 2026
Hepatocellular carcinoma in Europe: a shifting epidemiological landscape
27 octobre 2026
Neuromodulation for Neuropathic Pain: Which Techniques Offer the Greatest Relief?
23 octobre 2026